Daxor Biotech

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Daxor Corporation (NYSE: DXR) President and CEO Michael Feldschuh participated in the Benzinga Biotech Small Cap Conference held on March...